Three makers of Type 2 diabetes drug Metformin announced recalls Friday, the U.S. Food & Drug Administration reported. The reason for the voluntary recalls: the U.S. Food & Drug Administration ...
One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...
Pune, India, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The global Metformin Hydrochloride Tablets Market size is expected to gain momentum owing to the rising prevalence of diabetes during the forecast period ...
Granules Pharmaceuticals, Inc., Chantilly, VA is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the ...
Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to market a generic equivalent of ...
Indoco Remedies Ltd. announced the receipt of tentative approval from the US FDA for Abbreviated New Drug Application (ANDA) for canagliflozin and metformin hydrochloride tablets, 50 mg/500 mg, 50 ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
Dr. Reddy’s Laboratories Ltd. on Thursday announced its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S. market. It is the generic version of KOMBIGLYZE XR ...
A POPULAR drug prescribed to diabetes patients has been recalled over fears it contains large levels of a cancer-causing ingredient. Metmorfin hydrochloride was this week announced to contain an ...
One manufacturer of a widely-used drug to help diabetics produce insulin and help control their blood sugar recalled that drug on Wednesday because it contained levels of carcinogens higher than ...
Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), has received final approval from the United States Food and Drug Administration (USFDA) to market Empagliflozin and Metformin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback